Ownership history in ASSETMARK, INC · 3 quarters on record
This page tracks every 13F SEC filing in which ASSETMARK, INC reported a position in AKERO THERAPEUTICS INC (AKRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 1,276 | -163 | -11.3% | 0.00% | $61K | — |
| 2025 Q2 | ADDED | 1,439 | +870 | +152.9% | 0.00% | $77K | — |
| 2025 Q1 | INITIATED | 569 | — | — | 0.00% | $23K | — |